Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

25 projects found matching your search criteria :

  1. Fungal membrane modeling for selected antifungal compounds interactions

    Call: SONATA 20 , Panel: NZ9

    Principal investigator: dr Dominik Drabik

    Politechnika Wrocławska

  2. Strong bonds make perfect relationships. Covalent interactions between antibiotics and polymeric matrix as a key factor ...

    Call: PRELUDIUM 23 , Panel: ST5

    Principal investigator: Konrad Wojciech Kwiecień

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie

  3. Controlled release of active pharmaceutical ingredients (API) based on Carrier-Ion-API interactions

    Call: SONATA 19 , Panel: ST5

    Principal investigator: dr Mariusz Piotr Sandomierski

    Politechnika Poznańska, Wydział Technologii Chemicznej

  4. Decrypting the "sulfation code" of glycosaminoglycans for understanding their function in the extracellular matrix

    Call: OPUS 25 , Panel: ST4

    Principal investigator: dr hab. Sergey Samsonov

    Uniwersytet Gdański, Wydział Chemii

  5. The impact of UPF1 ATP mimetics on the mutant immunopeptidome

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr hab. Monikaben Padariya

    Uniwersytet Gdański, Międzynarodowe Centrum Badań nad Szczepionkami Przeciwnowotworowymi

  6. The new methodology for better understanding of ligand-RNA interactions.

    Call: OPUS 20 , Panel: NZ2

    Principal investigator: dr Filip Artur Stefaniak

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

  7. Homo- and heterometallic phosphine ruthenium and iridium complexes - design, synthesis, bioactivity and magnetic-nanofor...

    Call: PRELUDIUM 19 , Panel: ST4

    Principal investigator: Sandra Amanda Kozieł

    Uniwersytet Wrocławski, Wydział Chemii

  8. Seeking for CB1 and CB2 receptor ligands among drugs, drug metabolites, and phytochemical compounds

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Adam Stasiulewicz

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  9. Two in one" – novel fluorescent polymers for simultaneous imaging and drug delivery

    Call: OPUS 18 , Panel: ST5

    Principal investigator: dr hab. Agnieszka Zofia Wilczewska

    Uniwersytet w Białymstoku

  10. Comprehensive evaluation of the analytical capabilities of a capillary electrophoresis coupled with microscale thermopho...

    Call: OPUS 18 , Panel: ST4

    Principal investigator: dr hab. Paweł Mateusz Nowak

    Uniwersytet Jagielloński, Wydział Chemii

  11. Specific interactions of new antitumor unsymmetrical bisacridines, UAs, with DNA and ABC proteins and their potential to...

    Call: OPUS 17 , Panel: NZ7

    Principal investigator: prof. Zofia Mazerska

    Politechnika Gdańska

  12. Interactions of statins with biological membranes - implications for drug delivery research.

    Call: OPUS 16 , Panel: ST4

    Principal investigator: prof. Renata Bilewicz

    Uniwersytet Warszawski, Wydział Chemii

  13. Methods of preparation of prolate spheroidal particles and studies of their interactions with biological membranes in mo...

    Call: OPUS 15 , Panel: ST8

    Principal investigator: dr hab. Teresa Małgorzata Basińska

    Centrum Badań Molekularnych i Makromolekularnych PAN

  14. Studies of the interactions of carbon nanotubes with telomeric DNA by means of the molecular dynamics simulations

    Call: OPUS 14 , Panel: ST4

    Principal investigator: prof. Tomasz Pańczyk

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  15. Study of process of saccharides attachment to cell glucose receptors with consideration of mass transport phenomena.

    Call: PRELUDIUM 13 , Panel: ST8

    Principal investigator: Maciej Trzaskowski

    Politechnika Warszawska, Wydział Inżynierii Chemicznej i Procesowej

  16. Evaluation of interactions of aripiprazole, the atypical amtipsychotic drug, with the selected antidepressants in the ra...

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: dr hab. Zofia Maria Rogóż

    Instytut Farmakologii PAN

  17. Identification of Mycobacterium tuberculosis ligands binding human serum amyloid A (SAA) and biological function of tube...

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: dr hab. Bożena Renata Dziadek

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  18. Old drugs - new perspectives: modulation of antibiotics activity by caffeine and pentoxifylline

    Call: SONATA 11 , Panel: NZ7

    Principal investigator: dr Anna Woziwodzka

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  19. A coarse-grained model of protein - nanoparticles interactions for simulating the transport of drug molecules to their t...

    Call: PRELUDIUM 9 , Panel: ST4

    Principal investigator: dr Magdalena Anna Mozolewska

    Uniwersytet Gdański, Wydział Chemii

  20. Sythesis and the interactions of magnetic nanoparticles coated with human serum proteins with chosen drugs under normal ...

    Call: SONATA 8 , Panel: NZ7

    Principal investigator: dr Marta Ziegler-Borowska

    Uniwersytet Mikołaja Kopernika, Wydział Chemii

  21. Pharmacokinetic and pharmacodynamic interactions of the ECG modifying drugs - key covariates analysis.

    Call: SONATA 6 , Panel: NZ7

    Principal investigator: dr Barbara Helena Wiśniowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  22. Studies on the interactions of vanilloids with MOF materials for the purpose of drug delivery in anti-cancer therapies

    Call: PRELUDIUM 6 , Panel: ST5

    Principal investigator: Bartosz Jakub Marszałek

    Uniwersytet Jagielloński, Wydział Chemii

  23. Effect of aliskiren, a renin inhibitor, on the anticonvulsant activity of antiepileptic drugs in three seizure tests in ...

    Call: OPUS 5 , Panel: NZ7

    Principal investigator: dr Krzysztof Łukawski

    Instytut Medycyny Wsi im. Witolda Chodźki

  24. Characterization of interactions of active pharmaceutical ingredient-excipient in terms of compatibility and stability s...

    Call: PRELUDIUM 5 , Panel: NZ7

    Principal investigator: dr Piotr Mateusz Garbacki

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  25. Exploring new drug targets for efficacious therapy of neuropathic pain basing on the assessment and modulation of neuroi...

    Call: OPUS 2 , Panel: NZ4

    Principal investigator: dr hab. Joanna Gabriela Mika

    Instytut Farmakologii PAN